<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01666912</url>
  </required_header>
  <id_info>
    <org_study_id>PPI-12-0732</org_study_id>
    <nct_id>NCT01666912</nct_id>
  </id_info>
  <brief_title>Postpartum Etonogestrel Implant for Adolescents</brief_title>
  <acronym>PPImplant</acronym>
  <official_title>Etonogestrel-releasing Subdermal Implant for Adolescents in the Postpartum Period: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study comparing two groups of 48 adolescent women each. The
      intervention group will receive a contraceptive implant postpartum, prior to discharge from
      the hospital. The control group will receive a contraceptive implant at the usual 6 week
      postpartum clinic visit. During prenatal care, participants will be consented and screened
      for enrollment. After delivery, these women will be assessed and consented for enrollment
      into the study. Women who consent for enrollment will be randomized. Women will be followed
      up at 3 months, 6 months, 9 months, and 1 year after contraceptive implant insertion. At each
      follow up, women will be assessed for continuation of and satisfaction with this method of
      contraception.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Continuation at 1 Year</measure>
    <time_frame>12-14 months</time_frame>
    <description>The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>12 months</time_frame>
    <description>To assess satisfaction with the contraceptive implant inserted in the postpartum period, using a scale of 0-10, with 0 being &quot;not satisfied at all&quot; to 10 being &quot;extremely satisfied.&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid Repeat Pregnancy</measure>
    <time_frame>12 months</time_frame>
    <description>To assess rapid repeat pregnancies among the study population, ie, the number of participants who reported a repeat pregnancy within 12 months postpartum.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Adolescence</condition>
  <condition>Contraception</condition>
  <condition>Postpartum</condition>
  <arm_group>
    <arm_group_label>6 week postpartum contraceptive implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>randomized to receive contraceptive implant at normal 6 week postpartum visit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate postpartum contraceptive implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Contraceptive implant</intervention_name>
    <arm_group_label>6 week postpartum contraceptive implant</arm_group_label>
    <arm_group_label>Immediate postpartum contraceptive implant</arm_group_label>
    <other_name>Implanon, Nexplanon, etonogestrel contraceptive implant</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adolescents ages 14-24 attending prenatal care

          -  Greater than 20 weeks estimated gestational age

          -  English or Spanish-speaking

          -  Desire to use the contraceptive implant for contraception postpartum

          -  Anticipated delivery of a healthy infant vaginally or by cesarean.

        Exclusion Criteria:

        Participants will not be eligible for participation if they have any contraindications to
        contraceptive implant use, including

          -  current or past history of thrombosis or thromboembolic disorders

          -  hepatic tumors (benign or malignant)

          -  active liver disease

          -  undiagnosed abnormal genital bleeding

          -  known or suspected carcinoma of the breast (or a personal history of breast cancer)

          -  hypersensitivity to any of the components of the contraceptive implant.

          -  Current use of any medications known to induce hepatic enzymes, including but not
             limited to: barbiturates, bosentan, carbamazepine, felbamate, griseofulvin,
             oxcarbazepine, phenytoin, rifampin, St. John's wort, or topiramate

        Characteristics that would preclude involvement after delivery:

          -  Birth of a stillborn infant.

          -  Maternal ICU admission after delivery

          -  Maternal postpartum hemorrhage requiring blood transfusion

          -  Prolonged hospital stay (&gt;7 days) postpartum

          -  Coagulopathy associated with the pregnancy

          -  Severe pregnancy-induced hypertension

          -  Fever &gt;38 degrees C postpartum

          -  Adolescent women who are not competent to consent, secondary to stress from the labor
             process, for example severe pain or sleep deprivation, will not be offered enrolment
             into the trial
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of North Carolina Hospitals</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2012</study_first_submitted>
  <study_first_submitted_qc>August 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2012</study_first_posted>
  <results_first_submitted>January 13, 2017</results_first_submitted>
  <results_first_submitted_qc>March 20, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 1, 2017</results_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of North Carolina, Chapel Hill</investigator_affiliation>
    <investigator_full_name>Amy Bryant</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>adolescence</keyword>
  <keyword>contraception</keyword>
  <keyword>postpartum</keyword>
  <keyword>rapid repeat pregnancy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Etonogestrel</mesh_term>
    <mesh_term>Desogestrel</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>6 Week Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant at normal 6 week postpartum visit
Contraceptive implant</description>
        </group>
        <group group_id="P2">
          <title>Immediate Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum
Contraceptive implant</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>6 Week Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant at normal 6 week postpartum visit
Contraceptive implant</description>
        </group>
        <group group_id="B2">
          <title>Immediate Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum
Contraceptive implant</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="48"/>
            <count group_id="B3" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21" spread="2.58"/>
                    <measurement group_id="B2" value="21" spread="2.35"/>
                    <measurement group_id="B3" value="21" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="67"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Continuation at 1 Year</title>
        <description>The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.</description>
        <time_frame>12-14 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 Week Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant at normal 6 week postpartum visit
Contraceptive implant</description>
          </group>
          <group group_id="O2">
            <title>Immediate Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum
Contraceptive implant</description>
          </group>
        </group_list>
        <measure>
          <title>Continuation at 1 Year</title>
          <description>The number of participants using the contraceptive implant at one year postpartum among women who have the implant placed immediately postpartum vs. at 6 weeks postpartum.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction</title>
        <description>To assess satisfaction with the contraceptive implant inserted in the postpartum period, using a scale of 0-10, with 0 being &quot;not satisfied at all&quot; to 10 being &quot;extremely satisfied.&quot;</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 Week Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant at normal 6 week postpartum visit
Contraceptive implant</description>
          </group>
          <group group_id="O2">
            <title>Immediate Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum
Contraceptive implant</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction</title>
          <description>To assess satisfaction with the contraceptive implant inserted in the postpartum period, using a scale of 0-10, with 0 being &quot;not satisfied at all&quot; to 10 being &quot;extremely satisfied.&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.68" spread="1.36"/>
                    <measurement group_id="O2" value="8.29" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rapid Repeat Pregnancy</title>
        <description>To assess rapid repeat pregnancies among the study population, ie, the number of participants who reported a repeat pregnancy within 12 months postpartum.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 Week Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant at normal 6 week postpartum visit
Contraceptive implant</description>
          </group>
          <group group_id="O2">
            <title>Immediate Postpartum Contraceptive Implant</title>
            <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum
Contraceptive implant</description>
          </group>
        </group_list>
        <measure>
          <title>Rapid Repeat Pregnancy</title>
          <description>To assess rapid repeat pregnancies among the study population, ie, the number of participants who reported a repeat pregnancy within 12 months postpartum.</description>
          <units>participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="O2" value="5" lower_limit="4" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>6 Week Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant at normal 6 week postpartum visit
Contraceptive implant</description>
        </group>
        <group group_id="E2">
          <title>Immediate Postpartum Contraceptive Implant</title>
          <description>randomized to receive contraceptive implant prior to leaving the hospital postpartum
Contraceptive implant</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Amy G. Bryant, Assistant Professor</name_or_title>
      <organization>UNC_ChapelHill</organization>
      <phone>919-843-5633</phone>
      <email>amy_bryant@med.unc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

